1.Effect of iron on the stability of fat emulsion in total nutrient admixture in pediatrics
Linxia QIAO ; Qingya TANG ; Yanwen FEI ; Ying WANG
Chinese Journal of Clinical Nutrition 2010;18(2):111-114
Objective To evaluate the effect of iron on the stability of fat emulsion in total nutrient admixture (TNA) in pediatrics. Methods Based on intravenous nutrition preparation and handling protocols, 0,0.25, 0.50, 0.75, and 1.00 mg iron sucrose was added in each 100 ml TNA, respectively, and each dose was prepared for 10 bags. The stability of fat emulsion was observed by electron scanning microscopy. The pH and osmolality were determined at different time points (0, 24, 48, and 72 h). Results The fat particle size, percentages of particles > 0.5 μm, pH value, and osmolality were not significantly different among all the groups at different time points (all P > 0.05). The mean particle sizes of the fat emulsion were < 0.5 μm in all groups within 72 h.No fat particle with diameter > 5 μm was seen in each group. Conclusion TNA containing iron sucrose with concentrations range 0.25-1.00 mg per 100 ml is stable.
2.IL-17 A promotes differentiation and maturation of bone marrow-derived dendritic cells by cooperating with GM-CSF and LPS
Tengli LIU ; Sai QIAO ; Ningbo ZHENG ; Ying TANG ; Huili ZHAO ; Yue WANG ; Juyou LIANG ; Lida SUN ; Hong BAI
Chinese Journal of Immunology 2016;32(10):1477-1480
Objective:To investigate the effect of IL-17A on the differentiation and maturation of murine bone marrow-derived dendritic cells( BMDCs ) . Methods: Murine bone marrow cells were isolated and cultured in RPMI1640 complete medium in the presence of GM-CSF(20 ng/ml) for 8 days to induce differentiation of murine bone marrow cells to DC progenitors. Then these cells were treated with LPS(1 μg/ml) for 36 h which polarized immature DCs into mature DCs. Different concentrations of rmIL-17A(10 or 100 ng/ml) was added to the culture medium at different stages of BMDC differentiation and maturation. Co-stimulatory molecules expression on BMDC were analyzed by flow cytometry,and the culture supernatants were analyzed for IL-12p40 and IL-10 level by ELISA. Results:rmIL-17 could promote co-stimulatory molecules( CD40,CD80,CD86 and MHCⅡ) expression on BMDCs in a does-dependent manner,especially,the expression of CD40 and MHCⅡhad a significant increase in high concentration of rmIL-17A group;rmIL-17A was added while LPS induced maturation of BMDCs. CD40,CD80,CD86 and MHCⅡexpression on BMDC increased sharply in LPS plus rmIL-17A stimulation group,besides,CD86,MHCⅡ showed a higher level expression on BMDC with the increase of con-centration of rmIL-17A. Furthermore,secretion of IL-12p40 and IL-10 increased significantly in the group of DCs treated with LPS plus low concentration of rmIL-17 compared with the group without rmIL-17(P<0. 001). However,high concentration of rmIL-17A group showed significantly higher levels of IL-12p40(P<0. 001),but there was no difference in IL-10. Conclusion:IL-17A promotes the phe-notypic development of BMDC progenitors propagated in GM-CSF and cooperate with LPS to induce BMDC differentiation and matura-tion.
3.Relative research between social support and quality of life for leukemia patients
Ying-Chun MA ; Xiao-Jing DONG ; Ju-Ying TANG ; Qiao-Ling QIN ; Li-Li DONG
Chinese Journal of Modern Nursing 2009;15(4):313-315
Objective To investigate the condition of social support of leukemia patients, discuss the influence of social support on their life quality, and provide reference point for nursing of leukemia patients. Methods Perform SSRS questionnaire and WHO QoL-BREF on 50 leukemia patients during symptomatic relief period, another 50 healthy cases were as control group. The results were analyzed with mathematical statistics test. Results The relation between social support and life quality of leukemia patients is positive. Conclusions The integrated clinical, Familial and social support system is very important for improving the life quality of leukemia patients. Clinical workers, Family members and the whole society should be encouraged to provide more care to leukemia patients, and to improve both of their psychological and physiological health condition.
4.Clinical characteristics of 275 pediatric cases of acquired immune deficiency syndrome
Yan ZHAO ; Fujie ZHANG ; Zhihui DOU ; Yaowu CHENG ; Zhirong TANG ; Aiwen LIU ; Guoping PENG ; Xiaochun QIAO ; Hongxin ZHAO ; Lin PANG ; Ying YUN ; Zhongfu LIU
Chinese Journal of Infectious Diseases 2008;26(7):430-432
Objective To study the clinical characteristic of acquired immune deficiency syndrome (AIDS) patients younger than 15 years old and to explore the influence of human immunodeficiency virus (HIV) infection on them. Methods The clinical information, including demographic profile, clinical stages of the disease, laboratory test results and developmental status were gathered from 275 antiretroviral therapy naive patients. Results Seventy eight point nine percent patients were infected by vertical transmission. Sixteen percent were infected by receiving blood products. The average age was (7.6±3. 7) years, with 5 cases younger than 1 year old, 104 cases ranging from 1 - 5 years and 166 cases elder than 6 years. Seventy point one percent patients were classified as stage 3 or 4 according to World Health Organization definitions. The average CD4 count was ( 137 ± 159 )/μL, ( 304 ± 317 ) /μL and ( 1 246 ± 776 )/μL respectively in children elder than 6 years, ranging from 1 to 5 years and younger than 1 year. One hundred and eighty one cases suffered from anemia on different severity grading. The most common HIV related symdromes included persistent fever, skin damage, persistent diarrhea, oral candidiasis and recurrent upper respiratory tract infection. Among these infected children, 49. 6% showed height lower than x - 2s and 19. 9% showed weight lower than x - 2s. Conclusions Most survival pediatric AIDS patients are elder than 6 years. HIV infection can significantly affect the children's immune system function,growth and development.
5.Resection of ampulla-duodenal conjunction in the treatment of periampullary carcinoma
Ping BIE ; Jingxiu CAI ; Jikui LIU ; Yudong FAN ; Jian CHEN ; Jun DING ; Jianyong ZHU ; Qiao WV ; Chun TANG ; Chunlin FENG ; Ying ZHANG
Chinese Journal of General Surgery 2000;0(12):-
Objective To evaluate the clinical application of Vater ampulla-duodenal conjunction resection in the treatment of periampullary carcinoma. Methods From January 2005 to July 2006, 15 patients underwent this modus operandi, including carcinoma of duodenal papilla (6 cases), Vater ampulla (5 cases) and lower part of common bile duct (4 cases). The descending part of duodenum, Vater ampulla, head of pancreas and common bile duct were excised en bloc followed by reconstruction of GI conduit. Result One patient died of stress ulcer 2 months postoperatively, the 14 patients recovered uneventfully without any major complications, and 3-16 months follow-up found no tumor recurrence. Conclusion Vater ampulla-duodenal conjunction resection as a new surgical procedure provides enough tumor margin clearance while causing less trauma than standard pancreatoduodenectomy in selected cases of periampullary carcinoma.
6.Preparation and characterization of specific monoclonal antibodies against hexon of HAdV 3.
Rong ZHOU ; Hui-Ying SHENG ; Xin-Gui TIAN ; Chang-Bing WANG ; Si-Tang GONG ; Qiao-Lian CHEN
Journal of Southern Medical University 2008;28(6):1008-1010
OBJECTIVETo obtain the monoclonal antibody against hexon protein of human adenovirus.
METHODSBALB/c mice were immunized with purified recombinant hexon protein, and the spleen cells of the mice were isolated and fused with myloma cells. Four hybridoma cell strains were screened by indirect ELISA and cultured, and the sensitivity, specificity and virus neutralizing activity were analyzed with ELISA, Western blotting and neutralizing test.
RESULTSThe mouse ascites produced by these hybridoma cells contained specific monoclonal antibodies against hexon protein of human adenovirus as identified by ELISA and Western blot, and the antibody generated by 4C6 strain showed human adenovirus type 3-neutralizing activity.
CONCLUSIONThe monoclonal antibodies against hexon protein with high specificity have been successfully obtained, and these antibodies can be useful in developing assays for early diagnosis of HAdV3 infection and also in study of therapeutic drugs of the infection.
Adenoviruses, Human ; chemistry ; immunology ; Animals ; Antibodies, Monoclonal ; biosynthesis ; immunology ; Antibodies, Viral ; biosynthesis ; immunology ; Blotting, Western ; Capsid Proteins ; biosynthesis ; genetics ; immunology ; Enzyme-Linked Immunosorbent Assay ; Escherichia coli ; genetics ; Humans ; Hybridomas ; secretion ; Mice ; Mice, Inbred BALB C ; Recombinant Proteins ; biosynthesis ; immunology
7.Clinicopathologic analysis of pulmonary lymphangioleiomyomatosis.
Yu LÜ ; Song-Lin LIAO ; Xiao-Nai TANG ; Qiao YE ; Lei ZHANG ; Hong-Ying ZHAO
Chinese Journal of Pathology 2005;34(2):84-87
OBJECTIVETo investigate the clinicopathological features of pulmonary lymphangioleiomyomatosis (PLAM).
METHODSBy means of HE and immunohistochemistry (SP method) studies, the clinical and pathological features of 5 PLAM cases were analyzed and the related literature reviewed.
RESULTSPLAM was a rare lung disease of unknown etiology and was restricted to females who were generally pre-menopausal. Pathological features showed abnormal smooth muscle cells (LAM cells) line the airways, lymphatics and blood vesssels leading to airflow obstruction and replacement of the lung parenchyma by cysts. LAM cells were positive for HMB45. Clinically the disease was categorized by dyspnoea, haemoptysis, recurrent pneumothoraces and chylous effusions.
CONCLUSIONSPLAM should be considered when recurrent pneumothorax, haemoptysis and dyspnoea occur in females. Pathologic examination of lung tissue biopsy is required for confirmation of PLAM diagnosis.
Actins ; metabolism ; Adult ; Antigens, Neoplasm ; Biopsy ; Diagnosis, Differential ; Female ; Humans ; Immunohistochemistry ; Lung ; diagnostic imaging ; pathology ; Lung Neoplasms ; diagnostic imaging ; metabolism ; pathology ; Lymphangioleiomyomatosis ; diagnostic imaging ; metabolism ; pathology ; Matrix Metalloproteinase 2 ; metabolism ; Melanoma-Specific Antigens ; Middle Aged ; Neoplasm Proteins ; metabolism ; Tomography, X-Ray Computed
8.Clinical trial of aerosolized in halation of salbutamol suspension in the treatment of children with asthma
Min LI ; Yu TANG ; Er-Yao ZHAO ; Lei ZHANG ; Chao-Hui CHEN ; Jun-Ying QIAO
The Chinese Journal of Clinical Pharmacology 2017;33(19):1858-1861
Objective To evaluate the clinical efficacy of aerosolized inhalation of salbutamol suspension in the treatment of children with asthma and the influence of lung function,blood eosinophil (EOS) and immunoglobulin E(IgE).Methods A total of 160 children with asthma were randomly divided into treatment group (n =80 cases) and control group (n =80 cases).The control group was treated with inhaled budesonide 1.0 mg,5 min a time,twice a day,while the children in treatment group were treated combined with salbutamol 5 minutes a time,twice a day on the basis of control group.All patients were treated for 2 weeks.The clinical efficacy in two groups were observed.The changes of blood EOS and IgE at 3 months after treatment were observed.Results The total effective rate in treatment group was 98.68% (75/76 cases),had significant difference with that in control group,which was 84.13% (53/63 cases,P < 0.05).And 3 months after treatment,the forced vital capacity (FVC),forced expiratory volume in first second(FEV1),peak expiratory flow (PEF),vital capacity(VC) in treatment group were (79.34 ± 6.52) L,(80.12 ± 3.32) L,(82.08 ±9.62) L· min-1,(83.42 ±4.10) L,had significant difference with those in control group,which were (70.20±3.34)L,(68.25 ±2.90)L,(71.21 ±4.52) L · min-1,(73.17 ±2.34) L (all P<0.05).The absolute value of EOS and IgE in treatment group were (0.52 ± 0.13) × 109/L,(105.32 ± 62.35) ng · mL-1,had significant difference with those in control group,which were (0.96 ± 0.23) × 109/L,(222.58 ± 84.71) ng · mL-1(all P < 0.05).The control group occurred 1 cases (1.59%) of nausea,while treatment group occurred 2 cases(2.63%) of hoarseness,with no significant difference (P > 0.05).No drug allergy,nosocomial infections,rash and other adverse reactions occurred in two groups.Conclusion The application of glucocorticoid combined with salbutamol inhalation has significant effect on children with asthma,and can significantly reduce the levels of EOS and IgE in blood,and improve lung function.
9.Clinicopathological and prognostic analysis of 178 patients with hypopharyngeal cancer
Yong-Hong HUA ; Qiao-Ying HU ; Zhen-Fu FU ; Qiu TANG ; Wen-Dong WANG
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2012;47(7):540-544
Objective To study the clinicopathological characteristics and the prognostic factors in patients with hypopharyngeal cancer. Methods Clinical and pathological data of 178 cases with hypopharyngeal cancer from January 2000 to December 2006 were studied. Results Of the 178 hypopharyngeal cancer,the median survival time was 42.8 months ( 1 - 127 months).Total 3- and 5-year survival rates were 47% and 35%,respectively.The 5-year survival rates of stage Ⅰ + Ⅱ,stage Ⅲ and stage Ⅳ were 76.2%,46.7% and 29.6%,respectively. The second primary carcinoma occurred in 14.0% patients (25/178),of them 18 patients with synchronous carcinoma and 7 patients with metachronous carcinoma.The independent risk factors associated with the prognosis of these patients were T staging,N staging,clinical staging,performance status (PS),smoking index and treatment model (all P <0.01). Multivariate Cox analysis showed that smoking index,staging of tumor and treatment were independent risk factors of prognosis.The rate of larynx function preservation was increasing with years from 2000 to 2006.Conclusions Surgery plus radiotherapy is the most important treatment for the patients with hypopharyngeal cancer.Tumor stage and treatment model are important predictors of survival in patients with hypopharyngeal cancer.
10.Efficacy of ursodeoxycholic acid combined with Tongdan Decoction () on immunological indices and histopathological changes in primary biliary cirrhosis patients.
Guang-Dong TONG ; Hai-Hong TANG ; Chun-Shan WEI ; Ying-Jie CHEN ; Jin-Song HE ; Xiao-Zhou ZHOU ; Ying-Jun ZHENG ; Da-Qiao ZHOU
Chinese journal of integrative medicine 2012;18(1):16-22
OBJECTIVETo observe the efficacy of ursodeoxycholic acid (UDCA) combined with Tongdan: Decoction () on immunological indices and histopathological changes in patients with primary biliary cirrhosis (PBC) of IIor III histological stage.
METHODSSixty PBC patients were assigned randomly and equally: to the control group treated with UDCA alone and the treatment group treated with UDCA combined with Tongdan Decoction. The immunological indices and histopathological changes were detected before and after 24-week treatment, and the follow-up lasted for 1-3 years.
RESULTSAfter 24-week treatment, CD4(+)CD28(-) in the peripheral blood was lowered and CD4(+)CD25(+) was increased in both groups, and better effect was shown in the treatment group (P<0.01). The levels of IgM, IgG, and IgA decreased markedly after 96-week treatment in the treatment group (P< 0.05, P< 0.01), while in the control group, only the latter two showed significant decrease after 148 week (all P<0.05). At the end of the 3-year follow-up, the medians of histopathological CONCLUSIONCombined therapy of Tongdan Decoction and UDCA showed a better therapeutic effect: than UDCA monotherapy on PBC, especially in improving immunological indices and histopathological hepatic changes.
Antigens, CD
;
blood
;
Biomarkers
;
Drug Therapy, Combination
;
Drugs, Chinese Herbal
;
therapeutic use
;
Female
;
Humans
;
Immunoglobulin G
;
blood
;
Inflammation
;
blood
;
complications
;
Liver Cirrhosis, Biliary
;
blood
;
drug therapy
;
immunology
;
pathology
;
Male
;
Middle Aged
;
Ursodeoxycholic Acid
;
therapeutic use